ID

23707

Description

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00568841

Link

https://clinicaltrials.gov/show/NCT00568841

Keywords

Versions (2)
  1. 7/11/17 7/11/17 -
  2. 7/11/17 7/11/17 -
Uploaded on

July 11, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841

English

Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
≥ 18 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
untreated non-small-cell lung cancer stage iiib/iv
Description

Non-Small Cell Lung Carcinoma untreated TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0332155
UMLS CUI [1,3]
C3258246
life expectancy > 3 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
performance status ecog 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent systemic immune therapy, chemotherapy or therapy with any anticancer drug not indicated in the study protocol
Description

Immunotherapy Systemic | Chemotherapy | Antineoplastic Agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0003392
any investigational agent(s) within 4 weeks prior to study entry
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
previous administration of any egfr-targeted therapy (antibodies, small molecules and others)
Description

Targeted Therapy Epidermal Growth Factor Receptor | Antibodies | Small Molecule

Data type

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0034802
UMLS CUI [2]
C3495458
UMLS CUI [3]
C1328819
any medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information
Description

Medical condition Excludes Clinical Trial Completion | Medical condition Preventing Comprehension Patient Information | Mental disorder Excludes Clinical Trial Completion | Mental disorder Preventing Comprehension Patient Information

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205197
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0162340
UMLS CUI [2,4]
C1955348
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C0008976
UMLS CUI [3,4]
C0205197
UMLS CUI [4,1]
C0004936
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C0162340
UMLS CUI [4,4]
C1955348
Back to the top of the page

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT00568841

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma untreated TNM clinical staging
Item
untreated non-small-cell lung cancer stage iiib/iv
boolean
C0007131 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
performance status ecog 0-2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Immunotherapy Systemic | Chemotherapy | Antineoplastic Agents
Item
concurrent systemic immune therapy, chemotherapy or therapy with any anticancer drug not indicated in the study protocol
boolean
C0021083 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0003392 (UMLS CUI [3])
Investigational New Drugs
Item
any investigational agent(s) within 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])
Targeted Therapy Epidermal Growth Factor Receptor | Antibodies | Small Molecule
Item
previous administration of any egfr-targeted therapy (antibodies, small molecules and others)
boolean
C2985566 (UMLS CUI [1,1])
C0034802 (UMLS CUI [1,2])
C3495458 (UMLS CUI [2])
C1328819 (UMLS CUI [3])
Medical condition Excludes Clinical Trial Completion | Medical condition Preventing Comprehension Patient Information | Mental disorder Excludes Clinical Trial Completion | Mental disorder Preventing Comprehension Patient Information
Item
any medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information
boolean
C3843040 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C1955348 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C0205197 (UMLS CUI [3,4])
C0004936 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0162340 (UMLS CUI [4,3])
C1955348 (UMLS CUI [4,4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial